[Other] [Other]Pharmacokinetics and safety of a new free-base formulation of tenofovir alafenamide 25 mg in healthy volunteers: a randomized, open-label, four-period, fully replicated crossover bioequivalence study

Article0 Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-22 00:52
Reward20points

Kim, E., Shin, W., Yoo, H. et al. Pharmacokinetics and safety of a new free-base formulation of tenofovir alafenamide 25 mg in healthy volunteers: a randomized, open-label, four-period, fully replicated crossover bioequivalence study.
Naunyn-Schmiedeberg's Arch Pharmacol (2026).


https://doi.org/10.1007/s00210-026-05374-x

Reply

Use magic Donate Report

All Reply1 Show all posts
minhminh97 Post time Half hour(s) ago | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

Return to the list